STATCenter·
STAT+: FDA approves Replimune melanoma drug previously rejected twice
The FDA approved Replimune’s treatment for advanced melanoma, dealing the company and patient advocates a big win after a tumultuous saga.
Read at STAT →
Health · 1 sources covering this
STAT+: FDA approves Replimune melanoma drug previously rejected twice
The FDA approved Replimune’s treatment for advanced melanoma, dealing the company and patient advocates a big win after a tumultuous saga.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/82c9c096dd179659e336ef95c3473f330744759b" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: FDA approves Replimune melanoma drug previously rejected twice"></iframe>
